Fundraising FoxProfectus Biosciences
Baltimore, US · Delaware corporation
Find your way into Profectus Biosciences
Sign up to see every warm intro you have to Profectus Biosciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Profectus Biosciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
TG
Thomas G. PeaseExecutive
JN
Jeffrey N. MeshulamExecutive
TG
Thomas G. PaeseExecutive
AR
Alexander RichExecutive
MS
M.G. SarngaharanExecutive
Board
WH
William HaseltineBoard director
MG
Michael GreenebaumBoard director
TA
Thomas A. LynchBoard director
FC
Frederick C. TecceBoard director
BK
Brian K. AdamskyBoard director
TL
Terry LiermanBoard director
MS
M.G. SarngadharanBoard director
Reported raises · per SEC filings
Form D private placements$7.8M disclosed across 2 rounds · 2009–2016
▶$300KraisedDec 2016 · 5 investors · BiotechnologyRule 506(b)
▶$300KraisedDec 2016 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- William HaseltineDirector
- Michael GreenebaumDirector
- Thomas G. PeaseExecutive Officer, Director
- Thomas A. LynchDirector
- Frederick C. TecceDirector
- Brian K. AdamskyDirector
- Terry LiermanDirector
- Jeffrey N. MeshulamExecutive Officer, Director
- M.G. SarngadharanDirector
- Offering amount
- $4M
- Amount sold
- $300K
- Minimum investment
- $10K
- First sale
- May 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7.5MraisedAug 2014 · 1 investors · BiotechnologyRule 506(b)
▶$7.5MraisedAug 2014 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Thomas G. PaeseExecutive Officer
- Tom PeaseExecutive Officer
- Brian K. AdamskyDirector
- Jeffrey N. MeshulamDirector
- William HaseltineDirector
- Alexander RichExecutive Officer, Director
- Thomas A. LynchExecutive Officer
- M.G. SarngaharanExecutive Officer
- Frederick C. TecceDirector
- Michael GreenebaumDirector
- Offering amount
- $7.5M
- Amount sold
- $7.5M
- First sale
- Jul 2009
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Profectus Biosciences raised?
- Profectus Biosciences has disclosed $7.8M raised across 2 rounds.
- Where is Profectus Biosciences headquartered?
- Profectus Biosciences is headquartered in Baltimore, US.